NCT06005779

Brief Summary

Borderline personality disorder (BPD) is a difficult chronic mental illness. This diagnosis is common in Western countries. Our researchers want to study the outcome and its influencing factors of BPD for the first time in China. Patients with BPD who had been hospitalized in Wuhan Mental Health Center were selected as the subjects. The researchers retrospectively collected the most recent hospitalization data of these patients, and then prospectively follow up them for 2 years to see how their condition will change. By analyzing all data, researchers hope to know deeply about the development law of this illness, and to provide evidence for releasing these patients' suffering.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
270

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 22, 2021

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

August 15, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 22, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

August 22, 2023

Status Verified

August 1, 2023

Enrollment Period

2.8 years

First QC Date

August 15, 2023

Last Update Submit

August 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • remission rate

    The remission rate is calculated as the number of patients who no longer met the diagnostic criteria for BPD for at least 6 months divided by the total number of enrolled patients. The diagnostic tool is ICD-10 (F60.3).

    After the first follow-up, patients will be followed up every 6 months, and the total follow-up time was 2 years.

Secondary Outcomes (2)

  • social disability

    After the first follow-up, patients will be followed up every 6 months, and the total follow-up time was 2 years.

  • quality of life

    After the first follow-up, patients will be followed up every 6 months, and the total follow-up time was 2 years.

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Inpatients at the Wuhan Mental Health Center

You may qualify if:

  • Diagnosis of BPD based on ICD-10 (F60.3)

You may not qualify if:

  • Comorbidity with severe physical disease
  • Comorbidity with neurological diseases such as epilepsy
  • Comorbidity with mental retardation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wuhan Mental Health Centre

Wuhan, Hubei, 430014, China

Location

MeSH Terms

Conditions

Borderline Personality Disorder

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Study Officials

  • Fan Yang, Master

    Wuhan Mental Health Centre

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 15, 2023

First Posted

August 22, 2023

Study Start

October 22, 2021

Primary Completion

August 1, 2024

Study Completion

September 1, 2024

Last Updated

August 22, 2023

Record last verified: 2023-08

Locations